US Stock MarketDetailed Quotes

STIM Neuronetics

Watchlist
  • 0.885
  • +0.050+5.94%
Close Nov 22 16:00 ET
26.86MMarket Cap-725P/E (TTM)
Pre-Market
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Comments

    Jaguar8
    Jaguar8
    Oct 14 07:31
    NEWS
    $Neuronetics (STIM.US)$
    NeuroStar® Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with Depression
    Neuronetics, Inc. (NASDAQ: STIM) announced its participation at the American Academy of Child and Adolescent Psychiatry (AACAP) conference in Seattle, WA, from October 14th-19th. The company will present data on the NeuroStar TMS System in an oral presentation at the 'Research Pipeline: New Findings on Therapeutics' session. This presentation will ...
    Jaguar8
    Jaguar8
    Sep 25 07:33
    NEWS
    $Neuronetics (STIM.US)$
    Health Care Service Corporation Adds First-Line TMS Coverage for AdolescentsNeuronetics, Inc. (NASDAQ: STIM) announced that Health Care Service (HCSC) has expanded access to TMS (transcranial magnetic stimulation) for adolescents 15 and older with major depressive disorder (MDD). This policy update aligns with the recent FDA clearance of NeuroStar TMS Therapy as a first-line add-on treatment for this age group. HCSC, the largest customer-owned health insurer in the U.S...
    Trytosaveabit
    Trytosaveabit
    Sep 19 07:35
    News
    $Neuronetics (STIM.US)$ Expanded Health Policies Enhance TMS Therapy Access for Adolescents and Adults
    3 MINUTES AGO, 8:31 AM EDT
    VIA GLOBENEWSWIRE
    MALVERN, Pa., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced that additional payors have updated their TMS (transcranial magnetic stimulation) cove...
    Jaguar8
    Jaguar8
    Sep 16 07:32
    NEWS
    $Neuronetics (STIM.US)$
    NeuroStar® Releases Software Upgrades to Elevate Patient Care
    Neuronetics (NASDAQ: STIM) has announced significant upgrades to its NeuroStar Advanced Therapy and TrakStar® patient data management software. The enhancements focus on improving patient communication, streamlining clinical data capture, and strengthening cybersecurity. Key upgrades include:
    1. Enhanced Patient Communication: New CRM capabilities for automated SMS and email communication, secure insurance ...
Read more

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data